Are there any challenges associated with nanotechnology in cancer diagnostics?
Despite its potential, nanotechnology in cancer diagnostics faces several challenges:
1. Biocompatibility: Ensuring that nanoparticles and other nanomaterials are safe for use in the human body is crucial. 2. Regulatory hurdles: New diagnostic tools must undergo rigorous testing and approval processes, which can be time-consuming and expensive. 3. Scalability: Producing nanomaterials in large quantities while maintaining quality and consistency is a significant challenge. 4. Cost: Advanced nanotechnology-based diagnostic tools can be expensive, limiting their accessibility.
